Back to search

Peptide record

TPDB02732

Antibacterial Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02732
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 13-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
IRRRIRLIVRRQI
Physicochemical Analysis
C76H146N32O15
ANDCEGHKMFPSTWY
R
1748.20
13.10
6
0
6
+6
3.71
-0.346
172.31
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
6
R
0
N
0
D
0
C
0
E
1
Q
0
G
0
H
4
I
1
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 4 L: 1 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
13
C76H146N32O15
1748.20
13.10
+6
3.71
-0.346
Evidence Records 3 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
>100 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | >100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria. | Pharmaceuticals (Basel) | 2019
Evidence 2 Activity

Activity

10% Killing
Toxicity
100 µg/mL
Cytotoxic
10% Killing | 100 | µg/mL | target cell: Mouse epithelial Hepa 1-6 cells

Target

Mouse epithelial Hepa 1-6 cells

Source & Reference

NA
DBAASP
De Novo Design and In Vitro Testing of Antimicrobial Peptides against Gram-Negative Bacteria. | Pharmaceuticals (Basel) | 2019
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
10 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.31163671] 10% hemolysis at >100 µg/mL against human blood cells. | Cytotoxicity: [Ref.31163671] The cell viability of Hepa 1-6 induced by SP12 is 98.0%, 99.3%, 95.9%, 92.6%, 100% and 89.2% at peptide concentrations of 3.125, 6.25, 12.5, 25, 50 and 100 µg/mL.

Target

erythrocytes

Source & Reference

NA
DRAMP
Pharmaceuticals (Basel). 2019 Jun 3 12(2). pii: E82. doi: 10.3390/ph12020082.